Applied DNA Sciences (APDN)

Applied DNA Sciences (APDN) Stock Price & Analysis


APDN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.75 - $1.93
Previous Close$0.88
Average Volume (3M)33.81K
Market Cap
Enterprise Value$6.07M
Total Cash (Recent Filing)$7.15M
Total Debt (Recent Filing)$1.24M
Price to Earnings (P/E)-1.2
Feb 08, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.76
Shares Outstanding13,687,420
10 Day Avg. Volume54,639
30 Day Avg. Volume33,806
Standard Deviation0.54
Financial Highlights & Ratios
Price to Book (P/B)2.03
Price to Sales (P/S)15.46
Price to Cash Flow (P/CF)-2.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.68
Enterprise Value/Gross Profit0.50
Enterprise Value/Ebitda-0.69
Price Target Upside183.77% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Ownership Overview

51.43% Insiders
4.73% Mutual Funds
14.55% Other Institutional Investors
29.29% Public Companies and
Individual Investors


What was Applied DNA Sciences’s price range in the past 12 months?
Applied DNA Sciences lowest stock price was $0.75 and its highest was $1.93 in the past 12 months.
    What is Applied DNA Sciences’s market cap?
    Currently, no data Available
    When is Applied DNA Sciences’s upcoming earnings report date?
    Applied DNA Sciences’s upcoming earnings report date is Feb 08, 2024 which is in 60 days.
      How were Applied DNA Sciences’s earnings last quarter?
      Applied DNA Sciences released its earnings results on Dec 07, 2023. The company reported -$0.26 earnings per share for the quarter, beating the consensus estimate of -$0.265 by $0.005.
        Is Applied DNA Sciences overvalued?
        According to Wall Street analysts Applied DNA Sciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Applied DNA Sciences pay dividends?
          Applied DNA Sciences does not currently pay dividends.
          What is Applied DNA Sciences’s EPS estimate?
          Applied DNA Sciences’s EPS estimate is -$0.29.
            How many shares outstanding does Applied DNA Sciences have?
            Applied DNA Sciences has 13,687,420 shares outstanding.
              What happened to Applied DNA Sciences’s price movement after its last earnings report?
              Applied DNA Sciences reported an EPS of -$0.26 in its last earnings report, beating expectations of -$0.265. Following the earnings report the stock price went down -18.519%.
                Which hedge fund is a major shareholder of Applied DNA Sciences?
                Currently, no hedge funds are holding shares in APDN

                Company Description

                Applied DNA Sciences

                Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.

                Top 5 ETFs holding APDN

                Market Value
                Smart Score
                Vanguard Total Stock Market ETF
                iShares Core S&P Total U.S. Stock Market ETF
                Up to five ETFs with an Outperform Smart Score that hold APDN. The ETFs are listed according to market value of APDN within the ETF

                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                American Bio Medica
                Aptose Biosciences
                Aptevo Therapeutics
                International Isotopes
                Popular Stocks
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis